跳至主要内容
临床试验/IRCT20080901001165N42
IRCT20080901001165N42尚未招募3 期

To evaluate the efficacy and safty of Aloe vera capsule in gastroesophageal reflux disease patients and comparing the control of symptoms with pantoprazole

Tabib daru pharmaceutical company0 个研究点目标入组 120 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • Obtaining the informed consent of the patient.
  • Diagnosis of reflux has been confirmed by a physician Considering clinical and para clinical findings.
  • The patient's condition is not life-threatening.

排除标准

  • Have been treated with any interactive medication before intervention; such as H2 blocker inhibitors and herbal medicines or drugs that are harmful to treatment for reflux such as theophylline and the like.
  • Participate in another clinical trial at the same time.

研究者

发起方
Tabib daru pharmaceutical company

相似试验